An essential phase of skeletal myogenesis is the fusion of mononucleated myoblasts to form multinucleated myotubes. Many cell adhesion proteins, including integrins, have been shown to be important for myoblast fusion in vertebrates, but the mechanisms by which these proteins regulate cell fusion remain mostly unknown. Here, we focused on the role of focal adhesion kinase (FAK), an important nonreceptor protein tyrosine kinase involved in integrin signaling, as a potential mediator by which integrins may regulate myoblast fusion. To test this hypothesis in vivo, we generated mice in which the Fak gene was disrupted specifically in muscle stem cells ("satellite cells") and we found that this resulted in impaired myotube formation during muscle regeneration after injury. To examine the role of FAK in the fusion of myogenic cells, we examined the expression of FAK and the effects of FAK deletion on the differentiation of myoblasts in vitro. Differentiation of mouse primary myoblasts was accompanied by a rapid and transient increase of phosphorylated FAK. To investigate the requirement of FAK in myoblast fusion, we used two loss-of-function approaches (a dominant-negative inhibitor of FAK and FAK small interfering RNA [siRNA]). Inhibition of FAK resulted in markedly impaired fusion but did not inhibit other biochemical measures of myogenic differentiation, suggesting a specific role of FAK in the morphological changes of cell fusion as part of the differentiation program. To examine the mechanisms by which FAK may be regulating fusion, we used microarray analysis to identify the genes that failed to be normally regulated in cells that were fusion defective due to FAK inhibition. Several genes that have been implicated in myoblast fusion were aberrantly regulated during differentiation when FAK was inhibited. Intriguingly, the normal increases in the transcript of caveolin 3 as well as an integrin subunit, the ␤1D isoform, were suppressed by FAK inhibition. We confirmed this also at the protein level and show that direct inhibition of ␤1D subunit expression by siRNA inhibited myotube formation with a prominent effect on secondary fusion. These data suggest that FAK regulation of profusion genes, including caveolin 3 and the ␤1D integrin subunit, is essential for morphological muscle differentiation.
INTRODUCTION
Skeletal muscle terminal differentiation is a temporally ordered process characterized by the expression of the myogenic regulatory factor myogenin, cell cycle withdrawal, the expression of muscle-specific proteins, and myoblast fusion (Andres and Walsh, 1996) . Even though the molecular mechanisms regulating myoblast fusion remain largely unknown, many proteins have been shown to be essential for the fusion process to occur normally (Horsley and Pavlath, 2004; Chen et al., 2007) . In the Drosophila embryo, the cellular and subcellular events described during fusion include cell recognition, adhesion, alignment, the recruitment of electrondense vesicles and plaques, and membrane merging (Doberstein et al., 1997; Chen and Olson, 2004) . Studies in Drosophila have suggested the importance of pathways involving cytoskeleton remodeling during fusion . In vertebrates, two stages of fusion have been distinguished: a first phase in which myoblasts fuse to other myoblasts (which we refer to as "primary fusion") to form nascent myotubes, and a second phase in which fusion of additional myoblasts to the nascent myotubes allows myotube growth (which we refer to as "secondary fusion"). Secondary fusion is regulated by an NFATc2-dependent pathway (Horsley et al., 2003) .
Although many proteins have been reported to be essential for myoblast fusion, the link between these molecules and details of the molecular pathways controlling primary fusion remain to be determined. Experimental evidence, obtained primarily by inhibition studies carried out in vitro, implicates several transmembrane proteins such as neural cell adhesion molecule (NCAM), N-and M-cadherins, a disintegrin and metalloprotease 12 (ADAM12), ␤1 integrins, caveolin 3, and CD9 in the process of myoblast fusion (Galbiati et al., 1999; Abmayr et al., 2003; Gullberg, 2003; Horsley and Pavlath, 2004) . However, the mechanisms by which these proteins regulate fusion remain poorly understood, and genetic deletion studies have not confirmed an essential role of several of these molecules for myoblast fusion in vivo. The role of cell adhesion receptors in skeletal muscle has been particularly complex to analyze because they may exhibit redundant functions.
Integrins are heterodimeric proteins consisting of ␣ and ␤ subunits that serve as receptors for many extracellular matrix (ECM) ligands and some cell surface receptors (Van der Flier and Sonnenberg, 2001; Hynes, 2002) . Vertebrate skeletal muscle expresses many integrin subunits in developmentally regulated patterns, including the integrin ␤1 subunit and its partners ␣1, ␣3, ␣4, ␣5, ␣6, ␣7, ␣9, and ␣v Hirsch et al., 1998) . The requirement of ␤1 integrins for myoblast fusion was demonstrated in vivo and in vitro (Schwander et al., 2003) . The ␤1 integrin subunit has five isoforms with alternatively spliced cytoplasmic domains (de Melker and Sonnenberg, 1999) . The ␤1A isoform is present in many tissues, whereas ␤1D is a muscle-specific variant, the predominant ␤1 isoform in striated muscle, and highly conserved between species ( Van der Flier et al., 1995; Zhidkova et al., 1995; Belkin et al., 1996) . ␤1A is abundantly expressed in proliferating myogenic precursor cells, but during differentiation it is gradually replaced by the ␤1D isoform (Belkin et al., 1996) .
Focal adhesion kinase (FAK) has been identified as the key cytoplasmic tyrosine kinase that transmits integrinmediated signals at focal adhesions in several cell types (Schlaepfer et al., 2004) . Focal adhesions are regions of the plasma membrane in close contact with the ECM, organized around an integrin heterodimer core that connects the plasma membrane both to the ECM and the actin cytoskeleton via adaptor proteins, and enriched in signaling molecules. The localization of FAK at focal adhesions is dependent on its C-terminal focal adhesion targeting (FAT) domain (Hildebrand et al., 1993) . The FAT domain of FAK interacts with integrin-associated proteins such as paxillin, which is also a substrate of FAK Mitra et al., 2005) , and talin (Chen et al., 1995) . FAK can be activated by growth factors and G protein-linked stimuli, but the major mode of FAK regulation is integrin-dependent (Burridge et al., 1992; Guan and Shalloway, 1992; Hanks et al., 1992; Kornberg et al., 1992; Schlaepfer et al., 2004) . After integrin binding to ECM proteins, FAK undergoes autophosphorylation at Tyr397, creating a docking site for Src-family kinases and other proteins (Schaller, 2001) . Activation of FAK initiates intracellular signal transduction cascades that, in turn, regulate cellular processes such as migration, growth, survival, and differentiation (Schaller, 2001; Schlaepfer et al., 2004) . In muscle, FAK is phosphorylated during myoblast adhesion to fibronectin via an ␣5␤1 integrin-dependent pathway (Disatnik and Rando, 1999) . FAK phosphorylation is biphasic during C2C12 myoblast differentiation, and disruption of this temporal pattern interferes with normal myogenic differentiation (Clemente et al., 2005) . The level and phosphorylation of FAK are increased during stretch or load-induced hypertrophy in skeletal muscle (Fluck et al., 1999; Carson and Wei, 2000) . We recently reported that FAK is essential for the formation of costameres (Quach and Rando, 2006) , protein complexes that in addition to ensuring the mechanical link between myofibrils and the sarcolemma also may transduce hypertrophic signals to regulate gene expression (Carson and Wei, 2000) .
In this report, we investigate the requirement of integrin and FAK-mediated signaling for myoblast fusion. Our findings demonstrate that FAK activity is required for normal myoblast fusion in vitro and during muscle regeneration in vivo and that this is mediated at least in part by FAKdependent expression of caveolin 3 and ␤1D integrin subunit, essential regulators of the fusion process.
MATERIALS AND METHODS

Animals
The mouse SV129 strain was obtained from Charles River Laboratories (Hollister, CA). We generated mice (FAK SC -knockout [KO] mice) in which the fak gene disruption could be induced in satellite cells by tamoxifen treatment. To obtain these knockouts, Fak flox/flox mice carrying floxed alleles of FAK (Fakflox) (Beggs et al., 2003) were crossed with mice in which an inducible Cre (CreER) was knocked into the exon encoding the 3Ј-untranslated region (UTR) of the Pax7 gene (Brack et al., 2007) . To induce fak disruption, 2-mo-old Pax7-CreER,Fak flox/flox mice received 150 l of tamoxifen (20 mg/ml) by intraperitoneal injections for five consecutive days, and injury was performed at least 3 d after the last tamoxifen injection. Mice were genotyped by polymerase chain reaction (PCR) analysis of tail DNA by using the following primers for FAK: P2 (5Ј-GAATGCTACAGGAACCAAATAAC-3Ј) and P3 (5Ј-GAGAATCCAGCTTTGGCTGTTG-3Ј) (Beggs et al., 2003) and the following primers for Cre: Cre forward (5Ј-CACCCTGTTACGTATAGCCG-3Ј) and Cre reverse (5Ј-GAGTCATCCTTAGCGCCGTA-3Ј). The presence of the recombined Fak-flox allele was detected with primer P1 (5Ј-GACCTTCAACTTCT-CATTTCTCC-3Ј) and P2 (5Ј-GAATGCTACAGGAACCAAATAAC-3Ј) PCR primers (Beggs et al., 2003) . All animals were handled in accordance with guidelines of the Administrative Panel on Laboratory Animal Care of Stanford University (Stanford, CA).
Reagents
For immunoblot and immunostaining analysis, the following antibodies were used: mouse monoclonal anti-sarcomeric ␣-actin (Sigma-Aldrich, St. Louis, MO), mouse monoclonal anti-sarcomeric ␣-actinin (Sigma-Aldrich), mouse monoclonal anti-embryonic myosin heavy chain (eMyHC) (Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA), rabbit polyclonal anti-␣5 integrin (Millipore Bioscience Research Reagents, Temecula, CA), rabbit polyclonal anti-␤1A integrin subunit (Millipore Bioscience Research Reagents), mouse monoclonal anti-␤1D integrin (Novus Biologicals, Littleton, CO), rabbit polyclonal anti-FAK (Santa Cruz Biotechnology, Santa Cruz, CA), mouse monoclonal anti-caveolin 3 (BD Biosciences, San Jose, CA), rabbit polyclonal anti-FAK phosphotyrosine 397 (Santa Cruz Biotechnology), mouse monoclonal anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Ambion, Austin, TX), mouse monoclonal anti-myogenin (BD Biosciences Pharmingen, San Diego, CA), mouse monoclonal anti-vinculin (Sigma-Aldrich), horseradish peroxidase-linked sheep anti-mouse or donkey anti-rabbit (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom), Alexa Fluor 594 donkey anti-mouse (Invitrogen, Carlsbad, CA), Cy3-conjugated goat anti-mouse (GE Healthcare), Cy2-conjugated donkey anti-rabbit (Jackson ImmunoResearch Laboratories, West Grove, PA), and fluorescein isothiocyanate-conjugated goat anti-rabbit (MP Biomedicals, Aurora, OH) antibodies.
Analysis of Muscle Regeneration
For regeneration studies, tibialis anterior muscles of 2-to 4-mo-old mice were injured by injection of 50 l of BaCl 2 (1.2%). Muscles were collected and embedded for cryostat sectioning. Regeneration 3 d after injury was analyzed in eMyHC-and 4,6-diamidino-2-phenylindole (DAPI)-costained muscle sections by measuring the diameter and number of cells expressing eMyHC within the injured area. Regeneration 5 d after injury was analyzed in hematoxylin and eosin (H&E)-stained muscle sections by measuring the diameter and number of centrally nucleated regenerating myofibers within the injured area. Measurements were performed using Volocity analysis software (Improvision, Coventry, England).
Primary Cultures of Myoblasts
Limb muscles from young (14-to 30-d-old) mice previously injured with a 30-gauge needle were dissociated to isolate pure populations of myoblasts as described previously (Quach and Rando, 2006) . Primary cultures were plated on 5 g/ml laminin-1 (Invitrogen)/collagen-coated dishes and amplified in growth medium (GM) consisting of Ham's F-10 (Mediatech, Herndon, VA) supplemented with 20% fetal bovine serum (Mediatech), 2.5 ng/ml basic fibroblast growth factor (Promega, Madison, WI), and penicillin (200 U/ml)/ streptomycin (200 g/ml) (Invitrogen). To induce differentiation, myoblast cultures plated on 10 g/ml fibronectin (Calbiochem, San Diego, CA)-coated dishes were maintained in differentiation medium (DM) consisting of DMEM supplemented with 2% horse serum and penicillin/streptomycin. Myotubes were defined as cells with three or more nuclei. Cells with two nuclei were not counted as myotubes in order to exclude dividing cells.
Adenoviral Infection
Adenoviruses (Ads) expressing green fluorescent protein (GFP) (University of Iowa) or a FAT-GFP fusion protein (a generous gift from D. Ilic, StemLifeLine, San Carlos, CA) were amplified by infecting human embryonic kidney (HEK) 293 cells. HEK cells and medium were collected, frozen and thawed three times, centrifuged, and the supernatant containing adenoviruses was then aliquoted and stored. The viral titer in the supernatants was determined to be approximately ϳ10 9 infectious units/ml (Adeno-X Rapid Titer kit; Clontech, Mountain View, CA). Myoblasts were plated in GM at a density of 4 -4.5 ϫ 10 5 cells/60-mm dish previously coated with fibronectin and were infected with adenoviral constructs 6 h after plating. The medium was replaced after 24 h, and cells were left for 24 h in GM before switching to DM. More than 80% cells infected with Ad-FAT-GFP expressed GFP 48 h after infection. Negligible cell detachment was observed in cultures infected with FATexpressing adenovirus. ; Invitrogen) were used in these studies. Myoblasts were plated at a density of 1.2-1.5 ϫ 10 5 cells/35-mm dish on the day before the transfection. siRNA oligonucleotides (100 pmol/well) were transfected into myoblasts by using Lipofectamine 2000 (Invitrogen). The transfection medium was removed after 6 h and replaced with DM for ␤1D siRNA-transfected cells. Cells treated with FAK siRNA were switched to DM only 48 h after transfection, to allow the down-regulation of FAK at the protein level before the induction of differentiation. Negligible cell detachment was observed in FAK siRNAtreated cultures.
Small Interfering RNA (siRNA) Transfection
Western Blot Analysis
Muscles were homogenized and cells were scraped in lysis buffer (50 mM Tris-HCl, pH 7.5, 0.5% SDS, 20 g/ml aprotinin, 20 g/ml leupeptin, 10 g/ml phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate, 10 mM sodium pyrophosphate, 10 mM sodium fluoride, and 1 mM dithiothreitol). Protein (60 g) from total extracts was electrophoresed on 10% SDS-polyacrylamide gel electrophoresis gels and transferred to nitrocellulose membranes (GE Osmonics, Minnetonka, MN). The membranes were blocked for 1 h at room temperature with blocking buffer (phosphate-buffered saline [PBS] , 0.05% Tween 20, and 5% milk) and were then probed overnight at 4°C with primary antibody diluted in blocking buffer. All primary antibody incubations were followed by incubation with an appropriate horseradish peroxidase-coupled secondary antibody for 1 h at room temperature. An enhanced chemiluminescence system (GE Healthcare) was used to visualize the specific secondary antibody binding. GAPDH was used as loading control.
Immunofluorescence
For immunofluorescence analysis, myoblast cultures were fixed for 10 min in 4% paraformaldehyde. Permeabilization and blocking of nonspecific binding were done for 1 h with 1% normal goat serum or 5% donkey serum in PBS containing 0.1% Triton X-100. Samples were incubated overnight at 4°C with primary antibody diluted in the same solution. Specimens were washed with PBS containing 0.1% Triton X-100 and were then incubated with secondary antibody for 2 h at room temperature. After washes, coverslips were applied with VECTASHIELD (Vector Laboratories, Burlingame, CA). Fluorescence was viewed with an Axioskop microscope (Carl Zeiss, Thornwood, NY).
Fusion Index and Myonuclear Number Determinations
After the induction of differentiation, cultures were analyzed microscopically to determine the fusion indices. Using a 20ϫ objective and phase contrast, random fields were analyzed. Myotubes were defined as cells with three or more nuclei. The fusion index was determined as the percentage of nuclei in myotubes compared with the total number of nuclei in the field. Within a microscope field, the number of myotubes containing three to five nuclei, six to 10 nuclei, or Ͼ10 nuclei also was determined to calculate the myonuclear number. Approximately 100 myotubes were counted per dish. The percentage of myotubes containing the number of nuclei in each range was obtained by dividing by the total number of myotubes counted. Measurements were performed in triplicate in at least three independent experiments.
Time-Lapse Imaging
Cells were plated in 60-mm culture dishes coated with fibronectin and transfected with siRNA control or targeting FAK 24 h later. Forty-eight hours after transfection, cells were put in DM and analyzed using time-lapse microscopy. The cells were placed in an incubation chamber (Incubator S; Carl Zeiss) that maintained a constant temperature at 37°C and provided humidified 5% CO 2 . Images were acquired at 10-min intervals for 48 h by using an Axiovert 200M inverted microscope, Axiocam MRm camera, and Axiovision software (all from Carl Zeiss). The movie was exported and converted into a .mov file displaying images at the speed of 5 frames/s.
Microarray Data Analysis
Total RNA was extracted from primary cultures at 0, 14, and 41 h after differentiation by using TRIzol reagent according to manufacturer's instructions (Invitrogen). The subsequent steps were performed by the protein and nucleic acid biotechnology facility at Stanford University, including mRNA isolation and quality control, transcription to cDNA, reverse transcription to cRNA and biotinylation, fragmentation, hybridization to oligonucleotide Genechip Mouse Genome 430 2.0 array (Affymetrix, Santa Clara, CA), fluorescent labeling, optical scanning of the fluorescent chip, and data review. In total, six arrays, including three time points for each of the two types of cells (GFP or FAT expressing), were analyzed.
Microarray data were downloaded as .CHP files on Genesifter web-based program (http://www.genesifter.net/web/) by using median normalization. Affymetrix annotations for Genechip Mouse Genome 430 2.0 array were downloaded and added to the data set. Genes that received absent calls in the three control arrays were filtered out, which resulted in remaining 22,717 probe sets. We first searched for genes that were at least twofold up-regulated (cut-off Ͼ2) during differentiation at 14 h, 41 h, or both in control arrays and found 5831 probe sets. We then searched for genes that were up-regulated in controls but to a lesser extent in FAT-expressing cultures at 14 h, 41 h, or both (cut-off Ͻ0.75) and found 3203 probe sets. Uncharacterized probe sets were discarded, and only the probe set with highest intensity signals was retained for probe sets targeting the same gene. Finally, 1919 genes were further analyzed (Supplemental Table 3 ). Using a similar approach than for upregulated genes, we found that 6067 probe sets were down-regulated during differentiation in control cultures. At 14 or 41 h after differentiation, 2514 probe sets were less down-regulated in FAT-expressing cells compared with controls. After exclusion of uncharacterized probe sets and probe sets carrying redundant gene title, 1614 genes remained for further analysis (Supplemental Table 4 ). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and hierarchical clustering analyzes were performed using Genesifter.
Quantitative Reverse Transcription-Polymerase Chain Reaction (QRT-PCR)
Total RNA was extracted from cultured cells using TRIzol reagent (Invitrogen). For each sample, 2 g of total RNA was reversed transcribed using SuperScript first-strand synthesis system and oligo(dT) primers (Invitrogen). The levels of expression of ␤1D and total ␤1 integrin transcripts were individually determined by real-time quantitative PCR using primer sets designed to specifically amplify ␤1D spliced transcripts or total ␤1 integrin transcripts in SYBR Green reagent (Applied Biosystems, Foster City, CA). Primer sequences to detect ␤1D subunit were 5Ј-CATCCCAATTGTAGCAG-GCG-3Ј (forward) in exon 6 and 5Ј-GAGACCAGCTTTACGTCCATAG-3Ј (reverse) in exon D; and primer sequences to determine total ␤1 integrin expression were 5Ј-CATCCCAATTGTAGCAGGCG-3Ј (forward) and 5Ј-CGTGTCCCACTTGGCATTCAT-3Ј (reverse), both in exon 6 common to ␤1D and ␤1A isoforms. PCR reactions were run and analyzed using MyIQ SingleColor Real-Time PCR Detection system (Bio-Rad Laboratories, Hercules, CA). Reaction conditions were as follows: 10 min at 95°C and 45 amplification cycles (30 s at 95°C, 2 min at 60°C, and 30 s at 72°C). Mouse ␤1D subunit expression plasmid was obtained from Dr. Randall Kramer (University of California, San Francisco, San Francisco, CA) and used to determine the standard curve for ␤1D and total ␤1 integrin quantification following the recombinant DNA external standard method (Pfaffl, 2001 ). Determination of caveolin 3 mRNA level was performed using TaqMan probe (Applied Biosystems) following the manufacturer's instructions by using GAPDH for normalization. Each measurement was performed in triplicate in three independent experiments.
Statistical Analysis
Quantitative data are presented as means Ϯ SD of at least three experiments. Statistical analysis to determine significance was performed using paired Student's t tests. Differences were considered to be statistically significant at the p Ͻ 0.05 level.
RESULTS
Deletion of FAK In Vivo in Satellite Cells Affects Muscle Regeneration
The requirement of ␤1 integrins for myoblast fusion has been demonstrated both in vivo and in vitro (Schwander et al., 2003) . However, the downstream effectors of integrins that regulate myoblast fusion are unclear. To test whether FAK, as a downstream effector of integrins, is essential for myoblast fusion, we analyzed muscle regeneration in mice in which FAK was specifically disrupted in satellite cells (FAK SC -KO mice). Inducible targeted disruption of Fak in satellite cells was obtained by crossing Fak flox/flox mice (carrying alleles of FAK in which the second exon encoding the kinase domain was flanked by loxP sites with mice in which an inducible Cre (CreER) was knocked into the exon encoding the 3Ј-UTR of the Pax7 gene (Brack et al., 2007; Nishijo et al., 2009 ). Pax7 is a transcription factor expressed in adult satellite cells. In this system, CreER is expressed in satellite cells but translocates to the nucleus to catalyze recombination at loxP sites only in the presence of estrogen analogues such as tamoxifen.
Genotyping of tissues collected from control and FAK SC -KO mice confirmed the specific disruption of Fak in skeletal muscles only after tamoxifen treatment ( Figure 1A) . Hindlimb muscles were then injured by BaCl 2 injection. Regeneration was analyzed 3 d after injury when new myofibers started to form. Early regenerating myofibers expressing eMyHC were observed in injured areas ( Figure 1B ). Quantitative analysis revealed that the number of eMyHCexpressing myotubes was dramatically decreased in mice with the FAK deletion, although the diameters of the myotubes were comparable to controls (Figure 1, C and D) . These results suggest that FAK is essential for normal myotube formation during adult myogenesis. Muscles were also analyzed 5 d after injury when most regenerating myofibers had formed but were still immature. Analysis of muscle sections revealed that muscle from mice in which FAK was deleted in satellite cells displayed the characteristics of delayed regeneration such as smaller regenerating myofibers, heterogeneity in myofiber size, increased number of interstitial cells and increased interstitial space between myofibers ( Figure 1 , E-H). In keeping with the findings at day 3, the numbers of large fibers (Ͼ40 m) were much greater in the normal muscles ( Figure 1G ). However, on day 5, the regenerating muscle in FAK SC -KO mice also had a large number of small (Ͻ20 m), newly forming fibers, and as a result the median fiber diameter was significantly less in the FAK SC -KO muscle (Figure 1, G and H) , suggesting that FAK is essential for normal satellite cell-mediated myofiber formation. One month after injury, muscle morphology seemed similar in control and KO muscles (diameters of regenerating myofibers, 58.26 Ϯ 7.84 and 59.35 Ϯ 8.37 m, respectively). Therefore, although the initial phases of myoblast fusion are disrupted in the absence of FAK, there clearly are compensatory mechanisms that ultimately result in effective regeneration even if significantly delayed compared with control muscle.
FAK Expression during Myogenic Differentiation of Cultured Primary Myoblasts
To be able to study the mechanisms by which FAK regulates muscle cell fusion, we isolated primary myoblasts from mice and studied their differentiation in vitro. Skeletal muscle differentiation proceeds by the expression of muscle-specific proteins and the formation of multinucleated myotubes (Andres and Walsh, 1996) . When cultured in low serum conditions, myoblasts started to spread, elongate, then fuse to form multinucleated myotubes (Figure 2A ). Myoblast fusion was mostly completed within 48 h of the initiation of differentiation. Further maturation of the contractile apparatus resulted in observable sarcomeric striations and myotube contractions ( Figure 2A) . A transient and rapid increase of phosphorylated FAK (activated form of the protein) was observed at early time points of differentiation, and was accompanied by the transient up-regulation of myogenin, an early marker of terminal differentiation whose expression precedes the induction of muscle-specific structural gene expression such as sarcomeric ␣-actin ( Figure 2B ). As myotubes matured, the level of FAK protein declined, occasionally as early as 48 h after the initiation of differentiation but always at later time points ( Figure 2B ).
Inhibition of FAK by the Dominant-Negative Form FAT Inhibits Myoblast Fusion
FAK is a known as a major effector of integrin signaling (Mitra et al., 2005) , and ␤1 integrin subunits have been shown to be essential for myoblast fusion in vitro and in vivo (Schwander et al., 2003) . To test whether FAK may regulate cell fusion in skeletal muscle, we inhibited FAK in mouse primary myoblast cultures by adenoviral expression of its FAT domain, which acts as a dominant-negative inhibitor of FAK (Gilmore and Romer, 1996; Schaller, 2001 ). Myoblasts were infected with an FAT-GFP-expressing adenovirus (Ad-FAT) or a GFP-expressing adenovirus (Ad-GFP) as a control and then cultured in DM. After 14 h in DM, most control cells had elongated and begun to fuse to form nascent myotubes, whereas FAT-expressing cells had elongated but remained mostly mononucleated ( Figure 3A) . After 41 h in DM, control (GFP-expressing) cultures were composed of elongated myotubes containing a large number of nuclei, whereas FAT-expressing cells exhibited minimal fusion ( Figure 3A) .
The morphological observations were quantified by the determination of the fusion index in the cultures. The fusion index of FAT-expressing cultures was much lower than that of control cultures at every time point (Figure 3B ), indicating that FAK signaling is essential for myoblast-to-myoblast fusion ("primary" fusion) leading to the formation of nascent myotubes. The fusion index of both cultures reached a plateau about at the same time, but the plateau value of FAT-expressing cells was dramatically lower, suggesting that inhibition of FAK did not simply cause a delay of myoblast fusion. In FAT-expressing myotubes that did form, a lower average myonuclear content was observed compared with control cultures (Figure 3C ), indicating that FAK signaling is also essential for myoblast-to-myotube fusion ("secondary" fusion) allowing myotube growth. The number of FAT-expressing myotubes containing three to five nuclei was much higher than control myotubes, whereas FAT-expressing myotubes containing Ͼ10 nuclei were rarely observed.
FAK Inhibition Prevents Myoblast Fusion without Blocking the Expression of Muscle-specific Genes
To verify the inhibition of FAK by FAT expression, we analyzed the level of FAK phosphorylation by Western blots ( Figure 3D ). The transient increase of phosphorylated FAK induced during differentiation was inhibited when FAT was expressed, consistent with the fact that FAT competes with endogenous FAK for the localization at focal adhesions where FAK becomes normally phosphorylated. Surprisingly, expression levels of muscle-specific genes such as sarcomeric ␣-actin and ␣-actinin were similar in FAT-expressing and control cells ( Figure 3E ), even though myoblast fusion was impaired in FAT-expressing cells. The focal adhesion protein vinculin did not change appreciably. Immunostaining of differentiated control and FAT-expressing cultures revealed a similar proportion of cells positive for sarcomeric ␣-actinin (data not shown). These data suggest that inhibition of FAK selectively affects morphological differentiation without blocking the expression of muscle-specific genes induced during terminal differentiation.
Myoblast Fusion Is Prevented by FAK Inhibition Confirmed by Using siRNA
To confirm the requirement of FAK for myoblast fusion using an alternative approach, we inhibited FAK expression by siRNA. Myoblasts transfected with control siRNA or siRNA directed against FAK were cultured in DM. Efficient down-regulation of total and phosphorylated FAK in the cells was observed ( Figure 4A ). FAK is normally expressed at focal adhesions but could barely be detected in cultures treated with FAK siRNA (Figure 4B ), confirming the inhibition of FAK expression. In DM, control cultures contained many multinucleated myotubes, whereas FAK siRNA-treated cultures were mostly composed of elongated mono-or binucleated cells ( Figure 4C ). Time-lapse movies of control and FAK siRNAtreated cells undergoing differentiation confirmed the defect of fusion observed when FAK is inhibited (Supplemental Videos 1 and 2). After 48 h in DM, the fusion index and nuclear content of myotubes in control cultures had increased substantially, unlike for FAK siRNA-treated cells (Figure 4, D and E) . Together, these data demonstrated that inhibition of FAK, either by FAT expression or by siRNA, resulted in inhibition of myoblast fusion, suggesting an essential role of FAK in that process.
Microarray Analysis to Compare Gene Expression in Normal Versus Fusion-defective Cells
Our observations suggest that FAK signaling is essential for myoblast fusion. To identify FAK-regulated genes that may be involved in myoblast fusion, we used microarray analysis to compare the profile of FAT-expressing cultures, characterized by a fusion-defective phenotype, to the profile of control cells during myogenic differentiation. We investigated the expression profile of these cultures by extracting the total RNA before and at different times after the initiation of differentiation. Analysis was performed using well established Affymetrix arrays to determine which genes were differentially regulated in fusion-defective cells.
The global pattern of gene expression changes during differentiation of control cells was similar to changes that have been reported in C2C12 cells undergoing differentiation (Moran et al., 2002) . To determine genes that are associated with the fusion defect observed in FAT-expressing cells, we analyzed the expression profile of these cells compared with control cells. We searched for genes that were up-regulated in controls but to a lesser extent in FAT-expressing cultures at 14 h, 41 h, or both. We found 1919 genes as potential candidates regulating myoblast fusion (Supplemental Table 1 ), including such genes as CD9 and dysferlin (Tachibana and Hemler, 1999; de Luna et al., 2006) . Whether or not these candidate genes were expressed in proliferating myoblasts, they were either transiently or persistently upregulated during normal differentiation ( Figure 5A ). We analyzed these genes according to the KEGG (Kanehisa et al., 2008) to determine the most represented molecular pathways involved (Supplemental Table 2 ). Many of these genes are known to be involved in MAPK signaling, the regulation of actin cytoskeleton, focal adhesions, Wnt signaling and insulin signaling, all of which are known to interact with FAK pathways (Schaller, 2001; Cohen et al., 2002; Goel and Dey, 2002; Mitra et al., 2005) .
Because myoblast fusion is also dependent on the downregulation of specific genes (Cerletti et al., 2006) , we screened for genes that were down-regulated during normal differentiation but not in FAT-expressing cells. Using a similar approach, we found 1614 genes that failed to be downregulated in fusion-defective cells expressing FAT ( Figure  5A and Supplemental Table 3 ). Gene ontologies were analyzed using KEGG pathways (Supplemental Table 2 ).
FAK Inhibition Impairs Caveolin 3 and ␤1d Integrin Expression during Myogenic Differentiation
Many genes important for myotube formation failed to be normally regulated in fusion-defective cells expressing FAT (Supplemental Table 4 ). These observations suggest that expression of fusion-related genes is coordinated during myogenic differentiation and that FAK signaling may function upstream in the regulation of the fusion process and in the fusion gene hierarchy. Throughout the process of muscle terminal differentiation that drives the fusion of mononucleated myoblasts into multinucleated contractile myotubes, a switch of expression is observed from ubiquitous to musclespecific isoforms or members of multigene families (NadalGinard, 1990 ). This transcriptional transition is associated with structural and functional changes necessary for the formation of differentiated muscle tissue, including the expression of genes necessary for myoblast fusion. Because our primary interest concerns cell surface receptors that may play a role in muscle cell fusion, we searched for transmembrane proteins that have been reported to be involved in muscle development.
Among transmembrane proteins known to be important in myoblast fusion whose expression was dysregulated in fusion-defective cells was caveolin 3 (Galbiati et al., 1999) . A ubiquitously expressed member of the caveolin gene family, caveolin 2, failed to be normally down-regulated rapidly during myoblast differentiation whereas the muscle-specific form caveolin 3 failed to be normally up-regulated. We confirmed the aberrant expression of caveolin 3 in fusiondeficient cells by quantitative real-time RT-PCR and Western blot analyses ( Figure 5 , B and C). During muscle regeneration, caveolin 3 is transiently up-regulated (data not shown). As in vitro, we observed an impaired up-regulation of caveolin 3 protein expression during muscle regeneration in FAK SC -KO mice ( Figure 5D ). Because caveolin 3 has been shown to be required for myoblast fusion (Galbiati et al., 1999) , this provides a mechanism by which FAK may regulate fusion, by controlling the expression of profusion genes.
A muscle-specific gene that failed to be normally upregulated upon differentiation in our fusion-defective cultures, and of particular interest in terms of the relationship between FAK signaling and muscle cell fusion, was integrin ␤1D. Interestingly, this gene has not been shown to be (E) Expression of myogenic markers. Sarcomeric ␣-actinin and ␣-actin were induced normally in FAT-expressing cells, suggesting that the expression of muscle terminal differentiation proteins was not blocked when FAK was inhibited (representative blot of at least 3 independent experiments). Unlike FAK, the expression of focal adhesion protein vinculin did not seem to change appreciably during myogenic differentiation. Note that the muscle-specific isoform, metavinculin, which is of slightly greater molecular weight and thus runs just above vinculin and is recognized by the same antibody, increased during muscle differentiation and is similarly increased in FAT-expressing and control cells.
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Molecular Biology of the Cellregulated by FAK previously. To confirm that integrin ␤1D failed to be appropriately up-regulated in cells with inhibited FAK signaling, we analyzed ␤1D subunit mRNA expression by real-time RT-PCR. The expression of the ␤1D isoform transcripts was highly induced during myogenic differentiation, and that induction was suppressed in cells in which FAK signaling was inhibited by FAT expression (Figure 5B) . Interestingly, the level of total ␤1 integrin transcripts was also decreased in differentiated cells expressing FAT ( Figure 5B ). The proportion of ␤1D transcripts compared with the total amount of ␤1 integrins remained similar in control and FAT-expressing cells (22 and 20%, respectively, after 48 h of differentiation). Therefore, the decline in ␤1D transcript levels by FAK inhibition was a consequence of reduced expression of total ␤1 transcript rather than a shift in the proportion of alternative splice variants. We found that the induction of ␤1D subunit isoform, which had previously been shown to be associated with muscle differentiation (Belkin et al., 1996) , also was blocked at the protein level in a dose-dependent manner by the inhibition of FAK ( Figure 5C ).
Inhibition of ␤1D Integrins by siRNA Affects Secondary Fusion
The requirement of ␤1 integrins for myotube formation was previously shown using function-blocking antibodies (Rosen et al., 1992) . The report from Schwander et al. (2003) demonstrated that specific deletion of ␤1 integrins in skeletal muscle blocked the fusion of myogenic cells in vivo (Schwander et al., 2003) . The ubiquitous isoform ␤1A and the muscle-specific ␤1D isoform are expressed in mouse skeletal muscle, but ␤1A is gradually replaced during myogenic differentiation by ␤1D that becomes the predominant isoform in adult muscle (Belkin et al., 1996) . Insofar as ␤1D subunit expression correlates with myogenic differentiation and is impaired in fusion-deficient cells in which FAK is inhibited, we asked whether this isoform is required for myoblast fusion using an siRNA approach. Myoblasts were transfected with different doses of siRNA specifically directed against ␤1D subunit ("␤1D siRNA") and then cultured in DM. ␤1D subunit expression increased during differentiation in control cells but was barely detected in ␤1D siRNA-treated cultures ( Figure 6, A and B) , demonstrating an efficient blockade of ␤1D protein expression. By contrast, the ␤1A subunit was expressed in both control and ␤1D siRNA-treated cells ( Figure 6B ). Multinucleated myotubes did form in ␤1D siRNA-treated cultures ( Figure 6C) , and the fusion index of these cultures ultimately reached levels similar to controls with a slight delay ( Figure 6D ). However, interestingly, the myonuclear content of ␤1D siRNA-treated cultures was significantly lower than in control cultures after 72 h in DM, reflected by a much higher percentage of myotubes with few nuclei and much lower percentage of myotubes with many nuclei ( Figure 6E ). These data suggest an important role of ␤1D subunit in secondary fusion involved in myotube growth. Together, these results support the hypothesis that FAK signaling is essential for myoblast fusion by regulating ␤1D integrin expression, thereby highlighting the bidirectional signaling involved in integrin-FAK pathway during myogenesis.
DISCUSSION
The fusion of myoblasts into myotubes is one of the most critical events during skeletal muscle formation. How mononucleated myoblasts fuse to form multinucleated myotubes that later mature into myofibers is thus a fundamental question in the biology of skeletal muscle. Cellular and molecular events occurring during myoblast fusion have been extensively studied in Drosophila . In vertebrates, many individual proteins required for primary fusion have been identified (Jansen and Pavlath, 2008) , but an integrated molecular pathway has yet to be described.
Among transmembrane proteins, several integrins have been shown to be involved in myoblast fusion in vitro and in vivo (Gullberg, 2003) . FAK is known as a major effector of integrin signaling, and a prime candidate downstream of integrins to regulate myoblast fusion. In the present article, we show that FAK is transiently up-regulated during terminal differentiation and that inhibition of FAK, whether by the expression of a dominant-negative form of the protein, by siRNA knockdown, or by genetic disruption of Fak, results in impaired myoblast fusion in vitro as well as during muscle regeneration in vivo. Interestingly, expression of terminal differentiation genes was not blocked when FAK was inhibited, suggesting that FAK is important primarily for the morphological aspect of skeletal muscle terminal differentiation.
Evidence of an essential role of FAK for myoblast fusion in vivo is limited. In mice, genetic deletion of FAK results in early embryonic lethality, precluding analysis of the effects on myogenesis (Furuta et al., 1995) . In a study reporting the effects of FAK deletion in brain, it was noted (data not shown) that a muscle-specific deletion of FAK resulted in a myopathic phenotype (Beggs et al., 2003) , but a detailed characterization of this strain has not been reported. Studies in Drosophila have not demonstrated an essential role of FAK in myoblast fusion in invertebrates. Deletion of the fak56 gene, the Drosophila homologue of Fak sharing ϳ33% amino acid identity with human Fak (Schaller, 2001) , seems to result in no muscle defect, and the flies are viable and fertile (Grabbe et al., 2004) . However, with few exceptions limited to cell-cell adhesion receptors and actin remodeling regulators (Srinivas et al., 2007; Moore et al., 2007; Kim et al., 2007; Pajcini et al., 2008) , most molecules reported to be involved in vertebrate myoblast fusion have not been shown to be required for invertebrate myoblast fusion. It remains to be determined whether there is evolutionary divergence of the molecules and pathways involved in myoblast fusion or whether there is evolutionary conservation that has not yet been revealed by functional studies.
What Are FAK Downstream Targets during Myoblast Fusion?
The molecular mechanisms by which FAK and its downstream signaling regulate myoblast fusion need to be further investigated. Our microarray analysis has revealed genes potentially implicated in myoblast fusion and regulated by FAK signaling. The finding that FAK may be an upstream regulator of caveolin 3 expression is novel and requires further investigation, but it is particularly interesting that inhibition of FAK signaling ( Figure 3E ) and antisense-mediated reduction of caveolin 3 expression (Galbiati et al., 1999) both inhibit fusion without significantly affecting the expression of muscle-specific proteins in myoblasts induced to undergo differentiation. In vivo, down-regulation of caveolin 3 in zebrafish results in defects of myoblast fusion (Nixon et al., 2005) , and caveolin 3 knockout mice display a mild muscular dystrophy phenotype (Hagiwara et al., 2000; Galbiati et al., 2001) . We also have found that FAK signaling is essential for the normal up-regulation of the ␤1D integrin isoform and that the expression of this isoform is, in turn, essential for normal myoblast fusion. The regulation of ␤1D integrin expression by FAK signaling likely represents only one mechanism by which FAK is involved in secondary fusion, because inhibition of FAK results in a more extensive inhibition of fusion than does inhibition of ␤1D expression. Because FAK is at the intersection of many signaling pathways, it probably regulates myoblast fusion by targeting multiple pathways that remain to be fully determined. In addition to FAK-regulated ␤1D integrin expression that we observed, it was recently suggested that ␤1D integrin is required for stretch-activated phosphorylation of FAK during fusion of C2C12 myoblasts . Together, these observations suggest complex feedback regulatory loops between integrins and FAK during myoblast fusion. The involvement of FAK in cytoskeletal remodeling (Mitra et al., 2005) may be another important aspect of FAK function in fusion. In Drosophila, loss of function of the cytoskeleton regulators Mbc and Drac inhibits myoblast fusion (Rushton et al., 1995; Hakeda-Suzuki et al., 2002) . Mammalian homologues of Mbc and Drac are DOCK180 and Rac, respectively. By phosphorylating Cas and paxillin, FAK may recruit the Cas-Crk-DOCK180 -ELMO complex activator of Rac involved in actin assembly, protrusive activity, and modulation of focal complex stability at the leading edge of cells (Mitra et al., 2005) . Intriguingly, many downstream effectors of FAK signaling involved in cytoskeletal rearrangements have been shown to be essential for myoblast fusion, including DOCK180 and Crk in zebrafish (Moore et al., 2007) , ELMO ), Arp2/3 (Richardson et al., 2007 , Arf6 (Chen et al., 2003) , and members of the WASP family of proteins (Kim et al., 2007; Massarwa et al., 2007; Schafer et al., 2007) in Drosophila. Finally, the Rhoserum response factor pathway involved in the transcription of muscle-specific genes is integrin and FAK dependent (Carson and Wei, 2000) . In addition to controlling cell morphology and dynamics, remodeling of actin cytoskeleton is essential for the regulation of muscle gene expression (Formigli et al., 2007) . It will be interesting to investigate whether FAK play an essential function in regulating gene expression by controlling cytoskeletal dynamics.
Microarray analysis revealed that many genes failing to be normally up-regulated in fusion-deficient myoblasts expressing FAT belonged to mitogen-activated protein kinase (MAPK) pathway (Supplemental Table 2 ). The MAPK pathway regulates gene transcription in skeletal muscle and is activated by FAK signaling in many cell types (Schlaepfer et al., 1994 (Schlaepfer et al., , 1999 . The role of MAPK signaling in myogenesis is clearly complex, because MAPK activation has been implicated in both positive and negative regulation of myogenic differentiation, depending possibly on the cell lines and growth conditions used. Among MAPK family members, p42 and p38␣ MAPK activities seem to be essential for myotube formation and both can be activated by integrin signaling in skeletal muscle (Gredinger et al., 1998; Cuenda and Cohen, 1999; Perdiguero et al., 2007) . It is not known whether FAK is signaling through MAPK pathway to regulate the expression of profusion genes and myoblast fusion.
Are ␤1 Integrins Required for Normal Myoblast Fusion in Vivo?
Interest in the role of integrins for myoblast fusion was fostered by reports demonstrating that function blocking antibodies against ␤1 integrins inhibited myotube formation in vitro (Menko and Boettiger, 1987; Rosen et al., 1992) . Since then, the study of integrins in myoblast fusion has lead to conflicting results (Gullberg, 2003) . Attempts to confirm the requirement of ␤1 integrins for myoblast fusion in vivo has been difficult as the knockout embryos die before the effect on muscle can be studied, whereas heterozygous and chimeric mice have a normal phenotype (Fassler and Meyer, 1995; Stephens et al., 1995) . The fact that ␤1-deficient myoblasts isolated from chimeric mice were able to form myotubes in vitro was additional evidence that ␤1 integrins might not be essential for myoblast fusion (Hirsch et al., 1998) . However, it has been proposed that cells maintained in culture for long periods may develop compensatory mechanisms, thus masking an essential process during normal fusion (Gullberg, 2003) . In this regard, the development of mice displaying a muscle-specific deletion of the ␤1 integrin subunit provided an alternate interpretation. These mice die at birth, and analysis of their muscles indicates that ␤1 integrins are dispensable for myoblast proliferation, migration, and the expression of muscle-specific genes but are required for the fusion of myoblasts into multinucleated myotubes (Schwander et al., 2003) .
During myogenic differentiation in vitro and in vivo, it was shown that a switch of ␤1 isoform occurs, from the ubiquitously expressed ␤1A isoform to the muscle-specific ␤1D isoform (Belkin et al., 1996) . Because the ␤1D isoform is normally up-regulated upon differentiation but fails to do so in fusion-defective cells expressing an FAK inhibitor, we hypothesized that it may be involved in myoblast fusion. It was reported that myogenic conversion of NIH3T3 cells by expression of MRF4 activates an incomplete myogenic program characterized by the induction of muscle-specific gene expression such as myogenin, myosin heavy chain, troponin T, and muscle creatine kinase, but without cell fusion (Russo et al., 1998) . In this study, the defect of fusion was correlated with the inability of the cells to accumulate the transcripts for muscle-specific isoforms of the ␤1 integrin subunit and the transcription factor MEF2D (␤1D and MEF2D1b2, respectively), which was not the result of a generalized inability to perform muscle-specific differential splicing because other products such as ␣7A integrin and ␤-tropomyosin transcripts did undergo muscle-specific alternative splicing. Conversely, myogenic conversion of the C3H10T1/2 cell line by MRF4 expression resulted in biochemical differentiation, cell fusion, and ␤1D isoform expression. Our data suggest that ␤1D isoform mainly supports the process of secondary fusion involved in myotube growth, because inhibition of ␤1D expression by siRNA resulted in the formation of smaller myotubes without dramatically affecting the primary fusion process ( Figure 6E ).
Despite the evidence of the role of the ␤1D isoform in myotube formation and growth in vitro, data obtained from genetic deletion studies in mice do not demonstrate a requirement of the ␤1D isoform in muscle formation in vivo (Baudoin et al., 1998) . Such a dichotomy between in vitro inhibition studies and in vivo genetic studies also has been observed for other adhesion proteins implicated in myoblast fusion, including M-cadherin (Zeschnigk et al., 1995; Hollnagel et al., 2002) , ADAM12 (Yagami-Hiromasa et al., 1995; Kurisaki et al., 2003) , or NCAM (Knudsen et al., 1990; Cremer et al., 1994; Moscoso et al., 1998) . Transgenic mice rendered null for the expression of the ␤1D isoform do form skeletal muscles, suggesting that other integrins or transmembrane receptors may have overlapping functions and compensate for the lack of this isoform (Baudoin et al., 1998) . By contrast, mice in which the expression of the ␤1A is replaced by the expression of the ␤1D isoform have defective primary myogenesis and reduced skeletal muscle mass in mice that survived until birth, suggesting that the two integrin isoforms are not functionally equivalent (Cachaco et al., 2003) . In vitro, overexpression of either ␤1D or ␤1A isoform impairs myotube formation in C2C12 myoblasts (Cachaco et al., 2003) and in primary myoblasts (data not shown), suggesting that a precise regulation of either integrin protein levels or the signaling they mediate may be critical for fusion. Our studies both in vitro and in vivo provide evidence in a more regulated system that the ␤1D isoform is an essential downstream effector of myoblast fusion.
The role of caveolin 3 in myoblast fusion has not been clearly resolved based on gain-of-function and loss-of-function studies, both of which have been shown to disrupt myoblast fusion (Galbiati et al., 1999; Volonte et al., 2003) . Likewise, myopathic changes are seen in muscles of mice deficient in caveolin 3 and in mice in which caveolin 3 is overexpressed (Galbiati et al., 2000 (Galbiati et al., , 2001 ). These findings demonstrate that a precise regulation of the levels of caveolin 3, like ␤1 integrins, is essential for normal muscle development and homeostasis, a regulation perhaps mediated by FAK signaling.
The present study demonstrates that FAK is essential for initial myoblast fusion events but not for the induction of the myogenic terminal differentiation program. Using microarray analysis to compare gene expression in control cultures versus fusion-defective primary myoblast cultures, we found that FAK regulates the expression of a set of musclespecific genes specifically involved in myoblast fusion during early myogenic differentiation, including ␤1D integrins. Because FAK is a well known downstream effector of integrin signaling, these findings demonstrate bidirectional regulation between integrins and integrin effectors in the context of muscle cell terminal differentiation.
